[Significance of ursodeoxycholic acid in the eradication of Helicobacter pylori]

Schweiz Med Wochenschr Suppl. 1996:79:44S-46S.
[Article in German]

Abstract

In this pilot study we investigated the value of a fourteen-day regimen with amoxicillin (1 g bid), ranitidine (300 mg/d) and ursodeoxycholic acid (300 mg tid) in eradicating Helicobacter pylori. 15 patients with non-ulcer dyspepsia (reactive CLO test, positive histology or 13C urea breath test) were enrolled. Helicobacter pylori was eradicated in 6 of 13 patients (13C urea breath test 4 weeks after the end of treatment). 2 patients were not followed up because of too short treatment (< 1 week). Only 5/15 patients had no side effects (33%). These results strongly suggest that ursodeoxycholic acid in this application regimen is not of use in eradicating Helicobacter pylori.

MeSH terms

  • Adult
  • Aged
  • Amoxicillin / administration & dosage
  • Anti-Ulcer Agents / administration & dosage
  • Drug Therapy, Combination
  • Dyspepsia / drug therapy*
  • Dyspepsia / microbiology
  • Female
  • Gastrointestinal Agents / therapeutic use
  • Helicobacter Infections / drug therapy*
  • Helicobacter Infections / microbiology
  • Helicobacter pylori*
  • Humans
  • Male
  • Middle Aged
  • Penicillins / administration & dosage
  • Pilot Projects
  • Ranitidine / administration & dosage
  • Ursodeoxycholic Acid / administration & dosage*
  • Ursodeoxycholic Acid / adverse effects

Substances

  • Anti-Ulcer Agents
  • Gastrointestinal Agents
  • Penicillins
  • Ursodeoxycholic Acid
  • Amoxicillin
  • Ranitidine